Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension

European Journal of Clinical Pharmacology

Volumn 55, Issue 3, 1999, Pages 185-189

  Agabiti Rosei, E ^a   Ambrosioni, E ^b   Pirelli, A ^c   Stimpel, M ^d   Zanchetti, A ^e  

^a Ospedale Civile   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Ospedale Consorziale Policlinico   (Italy)

^d Schwarz Pharma AG   (Germany)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Hypertension; Menopause; Moexipril

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MOEXIPRIL; NITRENDIPINE;

ADULT; AGED; ANKLE EDEMA; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; ISOQUINOLINES; MIDDLE AGED; NITRENDIPINE; POSTMENOPAUSE; PRODRUGS; TETRAHYDROISOQUINOLINES;

EID: 0033052446     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050616     Document Type: Article

References (29)

1. 1. Castelli WP (1990) Cardiovascular disease in women. Am J Obstet Gynecol 158: 1553-1560
2. 2. Stampfer MJ, Colditz GA, Willet WC (1990) Menopause and heart disease. A review. Ann N Y Acad Sci 592: 193-203
3. 3. Bonithon-Kopp C, Scarabin P-Y, Darne B, Malmejac A, Guize L (1990) Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol 19: 42-48
4. 4. Kannel WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85: 447-452
5. 5. Beard CM, Kottke TE, Annegers JF, Ballard DJ (1989) The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on heart disease among 40-to 59-year old women, 1960 through 1982. Mayo Clin Proc 64: 1471-1480
6. 6. Bittner V, Oparil S (1993) Hypertension in women. In: Douglas PS (ed) Cardiovascular health and disease in women. WB Saunders, Philadelphia, pp 63-103
7. 7. Bush TL (1990) The epidemiology of cardiovascular disease in postmenopausal women. Ann N Y Acad Sci 592: 263-271
8. 8. Harlan WR (1994) Menopause: epidemiologic aspects. In: Crosignani PG, Paoletti R, Sarrel Pn et al (eds) Women's health in menopause. Kluwer Academic Publishers, Dordrecht, Boston, London, pp 1-6
9. 9. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE (1995) The primary prevention of coronary heart disease in women. New Engl J Med 332: 1758-1766
10. 10. Messerli FH, Garavaglia GE, Schmieder RE, Sungaard-Riise K, Nunez BD, Amodeo C (1987) Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 107: 158-161
11. 11. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1993) The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med 153: 154-183
12. 12. Burt VL, Cuttler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ (1995) Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population - data from the health examination surveys, 1960 to 1991. Hypertension 26: 60-69
13. 13. Brogden RN, Wiseman LR (1998) Moexipril. Drugs 55: 845-860
14. 14. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350: 757-764
15. 15. Edwards IR, Birelli C (1994) Harmonisation in pharmacovigilance. Drug Saf 10: 93-102
16. 16. Cacciabaudo JM, August P (1995) Female sex hormones and cardiovasular disease: implication for therapy. In: Laragh JH, Brenner BM (eds): Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven Press, pp 2391-2406
17. 17. Jensen J, Nilas L, Christiansen C (1990) Influence of menopause on serum lipids and lipoproteins. Maturitas 12: 321-331
18. 18. Manolio TA, Furberg CD, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, Bush TL, for the CHS Collaborative Research Group (1993) Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 88: 2163-2171
19. 19. Matthews KA, Kuller LH, Wing RR, Meilahn EN (1994) Biobehavioral aspects of menopause: lessons from the Healthy Women Study. Exp Gerontol 29: 337-342
20. 20. Weiss NS (1972) Relationship of menopause to serum cholesterol and arterial blood pressure: The United States Examination Survey of Adults. Am J Epidemiol 96: 237-241
21. 21. Oksa A, Gajdos M, Fedelesova V, Spustova V, Dzurik R (1994) Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension. J Cardiovasc Pharmacol 23: 79-86
22. 22. Suter PM, Vetter W (1995) Metabolic effects of antihypertensive drugs. J Hypertens Suppl 13: 11-17
23. 23. Cosenzi A, Waltman FL, van Es PN, de Leeuw PW (1994) Doxazosin versus nitrendipine: a double-blind comparative study in patients adhering to a sodium-restricted diet. Cardiovasc Drugs Ther 8: 473-477
24. 24. Landmark K, Forsman M, Lindberg K, Ryman T, Martmann-Moe K, Haaverstad S, Wiel S (1995) Nitrendipine and mefruside in elderly hypertensives: effects on blood pressure, cardiac output, cerebral blood flow and metabolic parameters. J Hum Hypertens 9: 281-285
25. 25. Furberg CD, Psaty BM (1995) Should calcium antagonists be first-line drugs in hypertension? Herz 20: 365-369
26. 26. Ad Hoc Subcommittee of the Liaison of the World Health Organisation and the International Society of Hypertension (1997) J Hypertens 15: 105-115
27. 27. Abraham S, Llewellyn-Jones D, Perz J (1994) Changes of Australian women's perception of menopause and menopausal symptoms before and after the climacteric. Maturitas 20: 121-128
28. 28. Hunter MS, Liao KL (1995) A psychological analysis of hot flushes. Br J Clin Psychol 34: 589-599
29. 29. von Muhlen DG, Kritz-Silverstein D, Barrett-Connor E (1995) A community-based study of menopause symptoms and estrogen replacement in older women. Maturitas 22: 71-78